Arthneeti

Bodal Chemicals Q1 FY27 Share Price & Earnings Call Analysis

₹156.69+5.00% today
Market cap
₹1,975 Cr
P/E
28.75
ROE
1.97%
PEG
-1.81
Price to sales
0.88
Debt to equity
0.70
52W high / low
₹202 / ₹43.5
Sales growth (5Y)
10.41%
EBITDA margin
8.05%
Net profit margin
1.11%
Promoter holding
56.99%
Sales (last year)
₹2,267 Cr

Bodal Chemicals Limited is one of India’s leading integrated Dyestuff companies and is the largest domestic manufacturer of Dye Intermediates. It offers a wide range of Dyestuffs, Dye Intermediates, Basic Chemicals, and its variants to diverse customers across India and the world. [1]

Guidance scorecard · Q1 FY27 call

What Bodal Chemicals Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

Revenue10–20%MarginsUp 0–2%CapexNone plannedFundraisingNone plannedOrder bookWhat management said

RevenueQ1 FY26 call

10–20%
  • Company targets to reach INR2,000-2,100 crores revenue in FY27, up from about INR1,900 crores currently.
  • Expecting 12%-13% EBITDA margin leading to INR70-80 crores net profit and 7%-8% return on investment.
  • Growth expected from ramp-up in benzene derivatives and TCCA business volumes in next 3-6 months.
  • Benzene derivatives currently at 20%-30% utilization, targeting 70%-80% utilization by Q3/Q4 FY26.
  • TCCA market share expected to improve post-import duty clarity, with production resuming as inventory reduces by Q3/Q4.
  • Focusing on consolidating existing businesses with limited capex for next 2-3 years, mainly small debottlenecking.

2 more points from Bodal Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY26 analysis

MarginsQ1 FY26 call

Up 0–2%

See what Bodal Chemicals Ltd said on margins — free account, 30 seconds.

Full Q1 FY26 analysis

CapexQ1 FY26 call

None planned
  • No major capex planned in the next couple of years; focus is on consolidating and optimizing the current setup.
  • Small debottlenecking or Brownfield expansions may happen but will be very limited in scale.
  • Strategic land sale of about 8 acres at Rajpura to a large chlorine consumer to develop pipeline chlorine buyers, not a real estate deal but a business collaboration.
  • The company has about 62 acres of surplus land for future expansions, ensuring capacity for growth over the next 10-15 years.

2 more points from Bodal Chemicals Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY26 analysis

FundraisingQ1 FY26 call

None planned

See what Bodal Chemicals Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY26 analysis

Order bookQ1 FY26 call

  • TCCA production was paused due to inventory build-up but is expected to resume with clarity in future demand, likely by Q3 or Q4 of FY26.
  • Benzene derivatives business is ramping up, with utilization expected to reach 70-80% by Q4 FY26, indicating growing orders.
  • Dye Intermediates and Dyestuff divisions are maintaining volume and revenue levels with some challenges in raw material prices.
  • The company expects growth in turnover to INR1,900-2,100 crores in FY26, supported by existing business and new projects.
Full Q1 FY26 analysis
Full Chemicals & Petrochemicals ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Bodal Chemicals Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sign up free to see every company in the sector ranking and track Bodal Chemicals Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Bodal Chemicals Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Bodal Chemicals Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +390332330339394422429443451454480490588
Expenses +363310307315368388396399404407457468519
Operating Profit27222324253433444748232269
OPM %7%7%7%7%6%8%8%10%10%10%5%4%12%
Other Income +496552512420153
Interest12131312162120202122201918
Depreciation15151415171717171718171717
Profit before tax5322-2-11812136036
Tax %39%31%26%49%-200%-19%124%34%-25%24%-8%0%11%
Net Profit +32112-1-0514106032
EPS in Rs0.220.180.100.080.16-0.09-0.020.431.150.760.480.022.55

Financials of Bodal Chemicals Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +1,0439081,2331,1421,4241,3751,2262,0551,5741,3951,7452,012
Expenses +8597581,0079461,1871,2371,1401,8351,4411,2841,5781,851
Operating Profit18415022619623613887220133111167161
OPM %18%16%18%17%17%10%7%11%8%8%10%8%
Other Income +519158131016-2129242
Interest271295919172941548279
Depreciation222629122128304753606970
Profit before tax139131204186219101551425151954
Tax %34%34%35%33%35%15%28%31%25%-37%4%12%
Net Profit +92861331221418640993861848
EPS in Rs8.417.8812.1810.0311.727.123.438.513.030.511.473.80
Dividend Payout %0%8%7%8%7%11%23%9%3%0%0%0%

Financials of Bodal Chemicals Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital222222242424242425252525
Reserves1352133416738059079571,0281,0531,0571,0801,132
Borrowings +234143151181171257454676760904911813
Other Liabilities +144132193194290267314385283294324385
Total Liabilities5345107071,0721,2901,4551,7492,1132,1202,2812,3392,356
Fixed Assets +1901922224376096568048179671,3141,3011,239
CWIP309192671470193686167
Investments221717636001300
Other Assets +3393164595996507899241,2279608869771,050
Total Assets5345107071,0721,2901,4551,7492,1132,1202,2812,3392,356

Financials of Bodal Chemicals Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +198131104718610-13-14290204114176
Cash from Investing Activity +-35-23-67-256-128-79-168-170-315-278-4111
Cash from Financing Activity +-162-109-23236-51761781813381-73-191
Net Cash Flow0-114-1377-3-387-0-5
Free Cash Flow16210745-22138-43-191-170-29-2969180
CFO/OP129%111%76%34%106%20%-4%11%223%182%65%109%

Financials of Bodal Chemicals Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6967569185121139105971008380
Inventory Days435760598691141141119139139106
Days Payable62677379918710281721029781
Cash Conversion Cycle5058437179124178165144137125105
Working Capital Days231821585065735549192027
ROCE %39%35%46%27%24%11%5%12%5%3%6%7%

Guidance history

How Bodal Chemicals Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY26 call →10–20%Up 0–2%None plannedNone planned—
Q4 FY25 call →10–20%FlatPlannedNone planned—
Q3 FY25 call →20–40%FlatNone plannedNone planned—
Q2 FY25 call →10–20%Up 2%+Planned—Rising

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

49out of 100

Momentum score · price trend

49 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+153.0%97%
Last 6 months+130.2%98%
Last 3 months+124.5%100%

The price is 22.4% below its all-time high of ₹202.02 (25 Sept 2026). Stocks more than 20% below their peak have their score halved, so 98 became 49.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Bodal Chemicals Ltd: 0.4 × 97 + 0.4 × 98 + 0.2 × 100 = 98, halved to 49 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Bodal Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd